Jameson Resources Limited (JAL.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.1 Million | -1.72 Million | -741.57 Thousand | -939.15 Thousand | -1.05 Million | -1.13 Million |
| Net Income | -1.24 Million | -1.81 Million | -860.64 Thousand | -841.4 Thousand | 105.1 Thousand | -1.13 Million |
| Depreciation & Amortization | 2894.00 | 3405.00 | 3230.00 | 4042.00 | 33.17 Thousand | 31.85 Thousand |
| Deferred income taxes | - | 39.81 Thousand | -125.01 Thousand | -7529.00 | -286.19 Thousand | 396.88 Thousand |
| Stock-based compensation | - | 51.79 Thousand | 57.39 Thousand | 60.19 Thousand | 114.18 Thousand | 201.75 Thousand |
| Change in working capital | 143.59 Thousand | -91.6 Thousand | 67.62 Thousand | -52.67 Thousand | 172.01 Thousand | -598.63 Thousand |
| Other non-cash items | -660.00 | 79.25 Thousand | 115.84 Thousand | -101.79 Thousand | -1.19 Million | -38.33 Thousand |
| Investing Cash Flow | -3.62 Million | -2.96 Million | -3.8 Million | -4.32 Million | -4.77 Million | -8.04 Million |
| Investments in PPE | 1.00 | -2.96 Million | -3.8 Million | -4.39 Million | -6.54 Million | -7.74 Million |
| Acquisitions | - | - | - | - | - | -7.73 Million |
| Investment purchases | - | - | - | - | - | -666.58 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | 29.48 Thousand |
| Other Investing Activities | - | -2.96 Million | -96.55 Thousand | 63.61 Thousand | 1.77 Million | 8.06 Million |
| Financing Cash Flow | 4.18 Million | 5.46 Million | 3.72 Million | 5.28 Million | 5.8 Million | 10.11 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -189.74 Thousand | -181.27 Thousand | -214.29 Thousand | - | -4810.00 |
| Common Stock Issuance | 3.5 Million | 5 Million | 3.14 Million | 4.74 Million | - | 750 Thousand |
| Other Financing Activities | 687.75 Thousand | 658.71 Thousand | 763.38 Thousand | 752.3 Thousand | 5.8 Million | 9.37 Million |
| Accounts receivables | 48.17 Thousand | -91.6 Thousand | 67.62 Thousand | -52.67 Thousand | 172.01 Thousand | -598.63 Thousand |
| Accounts payables | 95.42 Thousand | 309.87 Thousand | 161.37 Thousand | 730.00 | -47.04 Thousand | 288.36 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | -309.87 Thousand | -161.37 Thousand | -730.00 | 47.04 Thousand | -288.36 Thousand |
| Cash at beginning of period | 2.51 Million | 1.73 Million | 2.6 Million | 2.61 Million | 2.69 Million | 1.72 Million |
| Cash at end of period | 1.97 Million | 2.51 Million | 1.73 Million | 2.6 Million | 2.61 Million | 2.69 Million |
| Capital Expenditure | 1.00 | -2.96 Million | -3.8 Million | -4.39 Million | -6.54 Million | -7.74 Million |
| Effect of forex changes on cash | - | 3372.00 | -40.56 Thousand | -28.91 Thousand | -64.39 Thousand | 44.58 Thousand |
| Net cash flow / Change in cash | -538.58 Thousand | 776.99 Thousand | -868.1 Thousand | -9810.00 | -84.57 Thousand | 978.35 Thousand |
| Free Cash Flow | -1.1 Million | -4.69 Million | -4.55 Million | -5.33 Million | -7.59 Million | -8.88 Million |
| Breakdown | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -620.76 Thousand | -313.22 Thousand | -313.22 Thousand | -1.81 Million | -1.09 Million | -545.67 Thousand |
| Depreciation & Amortization | 1429.00 | 733.00 | 733.00 | 3405.00 | 1749.00 | 875.00 |
| Deferred income taxes | - | - | - | 39.81 Thousand | 33.93 Thousand | 33.93 Thousand |
| Stock-based compensation | - | 10.16 Thousand | 10.16 Thousand | 51.79 Thousand | 11.86 Thousand | 11.86 Thousand |
| Change in working capital | - | - | - | -91.6 Thousand | -45.8 Thousand | -45.8 Thousand |
| Other non-cash items | -51.51 Thousand | 87.05 Thousand | 87.05 Thousand | 79.25 Thousand | -5881.00 | 29.24 Thousand |
| Investing Cash Flow | -1.86 Million | -879.63 Thousand | -879.63 Thousand | -2.96 Million | -1.74 Million | -870.07 Thousand |
| Investments in PPE | -4.00 | -879.63 Thousand | -879.63 Thousand | -2.96 Million | -1.74 Million | -870.07 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.86 Million | 1.16 Million | 1.16 Million | 5.46 Million | 261.66 Thousand | 130.83 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -189.74 Thousand | - | - |
| Common Stock Issuance | 1.51 Million | 1.99 Million | - | 5 Million | - | - |
| Other Financing Activities | 350.58 Thousand | 1.16 Million | 1.16 Million | 658.71 Thousand | 261.66 Thousand | 130.83 Thousand |
| Accounts receivables | - | - | - | -91.6 Thousand | -45.8 Thousand | -45.8 Thousand |
| Accounts payables | - | - | - | 309.87 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | -309.87 Thousand | - | - |
| Cash at beginning of period | 2.64 Million | 2.51 Million | - | 1.73 Million | 5.08 Million | 5.08 Million |
| Cash at end of period | 1.97 Million | 2.64 Million | 64.74 Thousand | 2.51 Million | 2.51 Million | -1.28 Million |
| Capital Expenditure | -4.00 | -879.63 Thousand | -879.63 Thousand | -2.96 Million | -1.74 Million | -870.07 Thousand |
| Effect of forex changes on cash | - | -3934.00 | -3934.00 | 3372.00 | 1320.00 | 1320.00 |
| Net cash flow / Change in cash | -668.07 Thousand | 129.48 Thousand | 64.74 Thousand | 776.99 Thousand | -2.57 Million | -6.37 Million |
| Free Cash Flow | -670.85 Thousand | -1.09 Million | -1.09 Million | -4.69 Million | -2.83 Million | -1.41 Million |
MEDICAMEQ
OGN
OVCHY
8159
FEVR
SURFI